For this article:

26 Jan 2026·Source: The Indian Express
3 min
Science & TechnologySocial IssuesSocial IssuesNEWS

AIIMS Spearheads Battle Against Superbugs Amidst Antibiotic Resistance

AIIMS intensifies research on superbugs, exploring early diagnosis and infection control strategies.

AIIMS Spearheads Battle Against Superbugs Amidst Antibiotic Resistance

Photo by little plant

As antibiotic resistance grows, AIIMS is leading research efforts focusing on early diagnosis, identifying biomarkers, rational antibiotic use, and strict infection control. This initiative aims to combat the rise of superbugs, which pose a significant threat to public health by rendering many common infections untreatable.

Researchers are exploring novel methods for early detection and more effective treatment strategies to mitigate the impact of these drug-resistant organisms. The rise of antibiotic resistance is a global concern, threatening to reverse decades of progress in combating infectious diseases.

Key Facts

1.

AIIMS leading research on superbugs

2.

Focus on early diagnosis and infection control

3.

Antibiotic resistance poses a global health threat

UPSC Exam Angles

1.

GS Paper III: Science and Technology - Developments and their applications and effects in everyday life

2.

GS Paper II: Health - Issues relating to development and management of Social Sector/Services relating to Health

3.

Potential question types: Statement-based, analytical questions on the causes and consequences of antibiotic resistance

Visual Insights

Key Statistics on Antibiotic Resistance

Dashboard highlighting key statistics related to antibiotic resistance and its impact.

Estimated Deaths Due to AMR Globally
1.27 Million+20%

Antibiotic resistance is a major public health threat, leading to increased mortality.

Percentage of Hospital-Acquired Infections Resistant to Antibiotics
30-40%

High percentage indicates poor infection control and overuse of antibiotics in hospitals.

Investment in AMR Research and Development (USD Billions)
1.6 Billion

Increased investment is crucial for developing new antibiotics and alternative therapies.

More Information

Background

The history of antibiotic resistance is intertwined with the discovery and widespread use of antibiotics. Alexander Fleming's discovery of penicillin in 1928 marked the beginning of the antibiotic era. Mass production of penicillin began in the 1940s, revolutionizing the treatment of bacterial infections.

However, resistance to penicillin was observed almost immediately. The overuse and misuse of antibiotics in human medicine and agriculture have accelerated the development and spread of antibiotic resistance. The introduction of new classes of antibiotics in the mid-20th century temporarily outpaced resistance, but bacteria have consistently evolved mechanisms to evade these drugs.

The concept of 'superbugs' emerged as some bacteria developed resistance to multiple antibiotics, making infections increasingly difficult to treat.

Latest Developments

Recent developments in combating antibiotic resistance include increased surveillance efforts to track the spread of resistant bacteria, the development of new diagnostic tools for rapid detection of infections, and the exploration of alternative therapies such as phage therapy and antimicrobial peptides. In the last 2-3 years, there has been a renewed focus on antibiotic stewardship programs to promote responsible antibiotic use in healthcare settings and agriculture.

International collaborations, such as the Global Antimicrobial Resistance and Use Surveillance System (GLASS) by WHO, are playing a crucial role in monitoring and addressing the global threat of antibiotic resistance. Future outlook includes the development of new antibiotics with novel mechanisms of action, as well as strategies to prevent the emergence and spread of resistance through improved hygiene and sanitation practices.

Frequently Asked Questions

1. What are the key facts about AIIMS's work on superbugs that are important for the UPSC Prelims exam?

AIIMS is leading research efforts to combat superbugs by focusing on early diagnosis, identifying biomarkers, promoting rational antibiotic use, and implementing strict infection control measures. Remember that antibiotic resistance is a global health threat.

Exam Tip

Focus on the terms 'superbugs,' 'antibiotic resistance,' and 'biomarkers.' Understand the general concept rather than specific details.

2. What is antibiotic resistance, and why is it a global concern?

Antibiotic resistance occurs when bacteria evolve to withstand the effects of antibiotics, rendering these drugs ineffective. This is a global concern because it threatens our ability to treat common infections, potentially leading to increased morbidity, mortality, and healthcare costs.

3. Why is AIIMS taking the lead in researching superbugs and antibiotic resistance?

AIIMS, as a premier medical institution, is equipped with the resources and expertise to conduct research on emerging health threats. Their research aims to find solutions for early diagnosis, effective treatment, and prevention strategies against superbugs, contributing to national and global health security.

4. What are the recent developments in combating antibiotic resistance, as highlighted in the article?

Recent developments include increased surveillance to track resistant bacteria, new diagnostic tools for rapid infection detection, and exploration of alternative therapies like phage therapy and antimicrobial peptides. There's also a renewed focus on antibiotic stewardship programs.

5. How does the rise of antibiotic resistance impact common citizens?

The rise of antibiotic resistance means that common infections become harder and more expensive to treat. This can lead to longer hospital stays, increased risk of complications, and potentially higher mortality rates. It affects everyone, as even minor infections could become life-threatening.

6. What is the role of biomarkers in combating antibiotic resistance, according to the article?

Biomarkers can help in the early diagnosis of infections and in identifying the specific bacteria causing the infection. This allows for more targeted and effective antibiotic use, reducing the chances of resistance development. AIIMS is focusing on identifying these biomarkers.

7. What are some strategies for infection control mentioned in the context of AIIMS's research?

AIIMS is focusing on strict infection control measures to prevent the spread of superbugs. While the specific measures are not detailed, they generally include hand hygiene, proper sanitation, isolation of infected patients, and careful use of medical equipment.

8. What is the historical background of antibiotic resistance?

Antibiotic resistance emerged shortly after the introduction of antibiotics. While penicillin was discovered in 1928, its mass production in the 1940s revolutionized bacterial infection treatment. However, resistance to penicillin was observed almost immediately, highlighting the adaptive nature of bacteria.

9. What are the pros and cons of increased surveillance efforts to track the spread of resistant bacteria?

Pros include better understanding of resistance patterns and informing public health interventions. Cons include the cost of surveillance programs and potential privacy concerns related to data collection. However, the benefits of controlling the spread of superbugs generally outweigh the cons.

10. Why is this topic of AIIMS researching superbugs important news right now?

This topic is important because antibiotic resistance is a growing global health crisis. AIIMS's efforts highlight the ongoing need for research and innovation to combat this threat. The news underscores the urgency of addressing antibiotic resistance before it reverses decades of progress in treating infectious diseases.

Practice Questions (MCQs)

1. Consider the following statements regarding antimicrobial resistance (AMR): 1. AMR occurs when bacteria, viruses, fungi, and parasites change over time and no longer respond to medicines. 2. The primary driver of AMR is the overuse and misuse of antimicrobials. 3. AMR only affects humans and does not have implications for animal health or the environment. Which of the statements given above is/are correct?

  • A.1 and 2 only
  • B.2 and 3 only
  • C.1 and 3 only
  • D.1, 2 and 3
Show Answer

Answer: A

Statement 1 is CORRECT: Antimicrobial resistance (AMR) occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve to become resistant to antimicrobial drugs. This makes infections harder to treat and increases the risk of disease spread, severe illness, and death. Statement 2 is CORRECT: The overuse and misuse of antimicrobials are the primary drivers of AMR. This includes using antibiotics for viral infections, using incorrect doses, and not completing the full course of treatment. Statement 3 is INCORRECT: AMR affects not only humans but also animals, plants, and the environment. Resistant microbes can spread between these different sectors, posing a significant threat to public health, animal health, and ecosystem health.

2. Which of the following strategies is NOT typically included in a comprehensive approach to combatting antimicrobial resistance (AMR)?

  • A.Promoting rational use of antibiotics in human and animal health
  • B.Enhancing infection prevention and control measures in healthcare settings
  • C.Investing in research and development of new antimicrobials and diagnostics
  • D.Encouraging unrestricted over-the-counter sales of antibiotics to improve access
Show Answer

Answer: D

Options A, B, and C are all key components of strategies to combat AMR. Promoting rational antibiotic use, enhancing infection control, and investing in research are all essential for reducing the spread of resistance and developing new treatments. Option D is INCORRECT: Encouraging unrestricted over-the-counter sales of antibiotics would exacerbate the problem of AMR by promoting overuse and misuse of these drugs. Restricting access and promoting responsible use are crucial for combating AMR.

3. In the context of combating antimicrobial resistance (AMR), what is the significance of 'One Health' approach?

  • A.It focuses solely on improving human health outcomes related to infectious diseases.
  • B.It emphasizes the interconnectedness of human, animal, and environmental health in addressing AMR.
  • C.It prioritizes the development of new antibiotics for human use only.
  • D.It advocates for the complete elimination of antibiotics in animal agriculture.
Show Answer

Answer: B

The 'One Health' approach recognizes that human health, animal health, and environmental health are interconnected and interdependent. Addressing AMR requires a collaborative, multisectoral approach that considers the interactions between these different domains. This includes promoting responsible antibiotic use in both human and animal medicine, improving sanitation and hygiene practices, and monitoring the spread of resistant microbes in the environment. Option A is INCORRECT: One Health is not solely focused on human health. Option C is INCORRECT: One Health addresses all sectors, not just human use. Option D is INCORRECT: One Health promotes responsible use, not complete elimination.

GKSolverToday's News